FDA Inspection 1243882 — US Specialty Formulations LLC

US Specialty Formulations LLC — FEI 3010680515

The FDA completed an inspection of US Specialty Formulations LLC on July 2, 2024 in Allentown, PA. The inspection was classified OAI (Official Action Indicated — objectionable conditions were found and regulatory action is recommended). Product area: Drugs.

Inspection Details

Classification
Official Action Indicated (OAI) (OAI)
End Date
July 2, 2024
Fiscal Year
2024
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Allentown, PA (United States)